Advanced Search
MyIDEAS: Login to save this paper or follow this series

Drug Regulation in the Philippines

Contents:

Author Info

  • Allan Grand A. Sobrepeña
Registered author(s):

    Abstract

    Access to essential drugs is vital for the promotion of better health for the entire population. High prices of drugs are being used as an argument for greater government role in the drugs sector through effective regulation of the drug market. The high prices of drugs in the Philippines will serve as the background upon which the analysis of the intricacies of the drug issue will revolve. This paper provides a quick glance at the pharmaceutical sector at the global level and provide a more in-depth discussion of the pharmaceutical sector in the country. The paper explains why drug prices in the Philippines are higher compared to other neighboring countries using market failure particularly monopolistic tendencies of pharmaceutical companies to be specific. The paper draws recommendations that may help relevant stakeholders in coming up with effective decisions.

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL: http://www.esocialsciences.org/Download/repecDownload.aspx?fname=Document11662009160.1892511.pdf&fcategory=Articles&AId=2073&fref=repec
    Our checks indicate that this address may not be valid because: 403 Forbidden. If this is indeed the case, please notify (Padma Prakash)
    Download Restriction: no

    Bibliographic Info

    Paper provided by eSocialSciences in its series Working Papers with number id:2073.

    as in new window
    Length:
    Date of creation: Jun 2009
    Date of revision:
    Handle: RePEc:ess:wpaper:id:2073

    Note: Working Papers
    Contact details of provider:
    Web page: http://www.esocialsciences.org

    Related research

    Keywords: Philippines; drug; drug regulation; pharmaceutical industry; monopolistic pricing; drug prices; market failure; government failure; Philippine pharmaceutical market.;

    This paper has been announced in the following NEP Reports:

    References

    No references listed on IDEAS
    You can help add them by filling out this form.

    Citations

    Lists

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    Statistics

    Access and download statistics

    Corrections

    When requesting a correction, please mention this item's handle: RePEc:ess:wpaper:id:2073. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Padma Prakash).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.